All organisms have to cope with the deleterious effects of reactive oxygen species. Some of them are able to mount a transcriptional response to various oxidative stresses, which involves sensor proteins capable of assessing the redox status of the cell or to detect reactive oxygen species. In this article, we describe the design, synthesis and characterization of Zn$L ASD (HHCC), a model for the Zn(Cys) 2 (His) 2 zinc finger site of ChrR, a sensor protein involved in the bacterial defence against singlet oxygen that belongs to the family of zinc-binding anti-sigma factors possessing a characteristic H/C-X 24/25 -H-X 3 -C-X 2 -C motif. . Therefore, the Zn(Cys) 2 (His) 2 site of Zn$L ASD (HHCC) appears to be at least 5 times more reactive toward these two oxidants than that of a classical bba zinc finger. Consequences for the activation mechanism of ChrR are discussed.
Introduction
Organisms living in an aerobic environment have to cope with the deleterious effects of oxidative stress, which is caused by a family of molecules produced from dioxygen in the living cell, the so-called Reactive Oxygen Species (ROS).
1 ROS are classied into two categories according to their production pathways: Type I for those arising from electron(s) addition to O 2 (e. O 2 , demonstrating that sensing pathways exist for this ROS. [5] [6] [7] One of the best characterized is that of Rhodobacter sphaeroides. It involves the protein s E , a group IV sigma factor up-regulating the expression of the response against 1 O 2 stress. [8] [9] [10] [11] s E is negatively regulated by its cognate anti-sigma factor, ChrR. In normal conditions, the anti-sigma factor sequesters its cognate sigma factor (Fig. 1A) . Under 1 O 2 stress, the anti-sigma factor undergoes a structural change and releases its sigma factor, which can then bind RNA polymerase, up-regulating the expression of specic genes involved in the response to 1 O 2 stress. The anti-sigma factor interacts with the sigma factor mainly via its N-terminal domain, named antisigma factor domain (ASD). 10 It is estimated that 33% of the group IV sigma factors are regulated by an anti-sigma factor containing an anti-sigma factor domain. Among the predicted cytoplasmic group IV anti-sigma factors, 92% contain a conserved zinc binding motif H-X 3 -C-X 2 -C, classifying them in the zinc-binding anti-sigma factor (ZAS) subfamily. 8 In 2011, Andreini et al. classied 93% of the 15 763 known structures of protein zinc sites into a minimum set of structural motifs. 12 The two existing structures of ChrR 10 could not enter in any of the families dened by Andreini, which demonstrates the singularity of the zinc nger site of their anti-sigma factor domain. ChrR contains an anti-sigma factor domain featuring a HHCC zinc nger site with a H-X 24 -H-X 3 -C-X 2 -C motif (Fig. 1B) . Interestingly, RslA and RsrA, two ChrR homologs featuring also a zinc nger site -HHCC within a H-X 24 -H-X 3 -C-X 2 -C motif for RslA 13 and CHCC within a C-X 25 -H-X 3 -C-X 2 -C motif for RsrA 14 -are sensitive to oxidative conditions and trigger a response against oxidative stress.
13-16 Noteworthy, the zinc site of RsrA is described as a redox switch, acting as a detection module for disulde stress. A similar role was proposed for the zinc site of RslA to sense oxidative stress. [13] [14] [15] [16] It has been proposed that the oxidation of the ZAS protein zinc nger induces Zn 2+ release and unfolding of the anti-sigma factor domain, leading to dissociation of the ZAS protein from its cognate sigma factor. However, it was recently demonstrated that oxidation of zinc-binding cysteine of the ZAS zinc nger is not always sufficient to dissociate the anti-sigma factor-sigma factor complex. 17 Similarly, it has been hypothesized that the zinc site of ChrR could sense 1 O 2 via zinc-bound thiol oxidation inducing dissociation of the anti-sigma factor domain from s E , which is supported by the demonstration that (i) formation of the zinc nger site in the N-ter domain anti-sigma factor domain of ChrR is essential for the ChrR-s E complex formation, and (ii) the Zn-loaded anti-sigma factor domain alone is sufficient to sequester s E . Additionally, it was also shown that the C-terminal cupin-like domain of ChrR is required for 1 O 2 response in vivo, 10, 11 but there is no data ruling out the involvement of the zinc nger site -and its oxidation -in these studies. The full mechanism of activation of ChrR by 1 O 2 remains to be elucidated.
We have previously shown that small metallopeptides modelling zinc nger sites are useful tools to gain interesting insights into the reactivity of zinc ngers toward ROS at the molecular level (oxidation products, kinetic rates). [18] [19] [20] In particular, we have shown that a Zn(Cys) 4 
Results

Peptide design
To date, two crystal structures of anti-sigma factor domaincontaining proteins displaying a zinc nger site (HHCC type) have been elucidated: ChrR 10 and RslA. 13 Anti-sigma factor domains display four a-helices and among them, three are involved in the constitution of the zinc nger site, which is displayed in Fig. 1B . These three helices (H1, H2 and H3) are held together by the chelation of a Zn 2+ ion and by closely packed hydrophobic side chains within the heart of the 3-helix core. Helices H2 and H3 (Fig. 1B ) form a knuckle bearing the H-X 3 -C-X 2 -C conserved motif, coordinating the Zn 2+ ion. The fourth zinc ligand is a histidine residue located at the Nterminus resulting in an overall H-X 24 -H-X 3 -C-X 2 -C Zn 2+ -binding motif (Fig. 2) . In order to reproduce the reactivity of a given zinc nger site, it is important to perfectly reproduce the various features of the site that can inuence its reactivity. This includes the coordination sphere of the Zn 2+ ion, the folding of the peptide around and the hydrogen bonds that are established with the Zn 2+ -bound sulfurs. 18, 20, 23 It has been shown with RsrA that the anti-sigma factor domain can adopt different folds depending whether it is bound to its sigma-factor or not.
17 Since our aim is to better understand if the reactivity of ChrR's zinc site could play a role in the sensing of 1 O 2 , we aim here at reproducing the fold as complexed with s E . Hydrophobic cores proximal to the zinc nger site can be important to enhance Zn 2+ affinity to the model peptide and to ensure its proper folding. 24 For these reasons, we decided to include the three helices in our model.
The design of the model peptides was based on the sequence and X-ray crystallographic structure of ChrR anti-sigma factor domain (Fig. 2) , 10 which was re-engineered as follows. (i) In the HH motif present at the N-terminus, only the second residue is involved in Zn 2+ coordination as part of the canonical H-X 24 -H-
In order to avoid scrambling of Zn 2+ ligand, the rst histidine of the HH motif was changed for a lysine.
(ii) Helices H1, H2 and H3 present several hydrophobic side chains that point toward the exterior of the structure because they are involved in the interaction with the sigma factor s E . In order to favour the correct fold of our model peptide and to ensure solubility, these hydrophobic amino acids were randomly changed for polar amino acids (E, Q or K). (iii) As b-branched amino acids such as threonine or valine may destabilize ahelices, 25 two threonines located in helices H1 and H2, and pointing toward the exterior of the structure were changed for lysines. Similarly, glycines in helix H3, which may destabilize a helical fold, were changed for glutamine and alanines. (iv) The C-terminus of the peptide was amidated to remove the carboxylate charge that could destabilize the C-terminus of helix H3.
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(v) Non-essential aspartates and arginines were changed for glutamates and lysines to avoid side reactions during solid phase peptide synthesis (SPPS) and maximize synthesis yields. This led to peptide L 1 , whose sequence is displayed in Fig. 2 . As a rst try to model the anti-sigma factor domain zinc nger, this 46-amino acid peptide was synthetized by SPPS. Unfortunately, when dissolved in various buffers at pH around 7, L 1 precipitated when Zn 2+ was added. Mapping charged amino acids of the L 1 sequence onto the 3-helix motif of ChrR using Pymol
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revealed that most of the negatively charged glutamate residues are clustered on one face of the structure whereas positively charged lysines are clustered on another face. Suspecting that this could be the reason for precipitation of the Zn 2+ complex, the charged amino acids were re-distributed in the sequence for random disposition onto the 3-helix surface. This led to peptide L ASD (HHCC) (Fig. 2) , which was synthetized by SPPS. Note that four pseudoproline dipeptides 28 were used to avoid aggregation of the elongating chain during synthesis (see ESI † for details).
Zinc binding and folding properties
The metal binding properties of L ASD (HHCC) were investigated by combination of UV-Vis absorption, circular dichroism (CD) and NMR. Titrations monitored by UV absorption were used to determine the stoichiometry of the peptide-metal complexes. Upon addition of Zn 2+ in a buffered peptide solution, an increasing absorption band is observed at ca. 220 nm, which corresponds to Cys$S À / Zn 2+ ligand-to-metal charge transfer (LMCT) transitions (Fig. 3A) . 24 This signal increases linearly up to one equivalent of zinc and plateaus aerwards (inserts Fig. 3A ). This indicates the formation of a 1 : 1 complex only, i.e. 20, 24, 30, 31 From these data, we can reasonably infer the formation of a tetrahedral 1 : 1 Zn$L ASD (HHCC) complex with (Cys) 2 (His) 2 coordination. Thereaer, the folding of the peptide was investigated by CD (Fig. 3B) . The CD spectrum of the metal-free L ASD (HHCC) shows an intense negative signal with minimum at ca. 200 nm and a shoulder at ca. 222 nm. This corresponds to a random coil peptide with a small content of helical fold. In agreement with absorption studies, upon titration of L ASD (HHCC) by Zn 2+ , evolution of the CD spectrum is observed up to 1 eq. Zn 2+ with a clean isodichroic point at 205 nm, thereby conrming the formation of a complex with 1 : 1 stoichiometry only. The spectrum of Zn$L ASD (HHCC) is characteristic of a peptide with major helix content, as expected for this model. In order to determine the Zn 2+ binding constant of In order to conrm that the N-terminal histidine, which is remote from the core H-X 3 -C-X 2 -C binding motif in the sequence, is bound to the Zn 2+ ion in our Zn$L ASD (HHCC) model, a peptide variant with the N-terminal histidine replaced by an alanine, namely L ASD (AHCC), was synthesized ( Fig. 2 and ESI †). Upon Zn 2+ titration, the formation of a 1 : 1 complex only is evidenced by both UV-Vis absorption and CD spectroscopies ( Fig. 3A and B) . The spectral features are very similar for both peptides, including LMCT absorption and CD spectra, either in their Zn-free and Zn-loaded forms. (Fig. 4A , top, and ESI †). Many of them present 3 J HN,Ha < 6 Hz indicative of helical folding (Table S2 and Fig. S4 of ESI †) . The 2D NOESY spectrum shows numerous correlation peaks corresponding to non-sequential NOEs that are characteristic of helical folding (Fig. S4 of ESI †) . Additionally, several long-range NOEs between hydrophobic amino acid remote in the sequence indicate the formation of a hydrophobic core. This suggests the formation of a Zn 2+ complex with a well-dened stable conformation. On the contrary, the 1 H NMR spectrum of Zn$L ASD (AHCC) (Fig. 4A,   bottom) shows very broad resonances in the amide NH region although this complex displays a similar helix content as Zn$L ASD (HHCC) as judged from its CD spectrum. This suggests a conformational equilibrium for Zn$L ASD (AHCC). Indeed, the coordination of the N-terminal histidine to the Zn 2+ ion is not necessary to fold the three helices, as indicated by CD but it plays a major role in freezing the conformation of the peptide in HHCC variant. Finally, the structure of Zn$L ASD (HHCC) was calculated using X-PLOR with 466 H-H distance constraints (142 intraresidue, 138 sequential and 186 medium-and longrange) extracted from the NOESY spectrum and 35 f dihedral constraints derived from 3 J HN,Ha values. The superimposition of the ten lowest energy structures, which is depicted on Fig. 4B shows that Zn$L ASD (HHCC) adopts a well-dened conformation with three helices (the backbone root mean square deviation over the ten structures is 0.83Å). The zinc nger site caps this three-helix domain (Fig. 4C) . The superimposition of the lowest energy structure of Zn$L ASD (HHCC) with the zinc nger site taken from the crystallographic structure of ChrR anti-sigma factor domain (Fig. 4D) shows that the model reproduces almost perfectly the fold of the native protein, including helices H1, H2 and H3 as well as the loops between the helices. To summarize, L ASD (HHCC) is able to bind only one Zn 2+ ion to form a tetrahedral Zn(Cys) 2 (His) 2 site that folds the peptide into a unique 3-helix conformation reproducing almost perfectly that of ChrR anti-sigma factor domain.
Zn$L ASD (HHCC). The intensity of this band is
D3 ¼ 6600 M À1 cm À1 ,L ASD (HHCC) at pH 7.0, K ZnL ASD (HHCC) ¼ [Zn$L ASD (HHCC)]/([Zn 2+ ] [L ASD (HHCC)]),
Oxidation of Zn$L ASD (HHCC) by H 2 O 2
The reactivity of Zn$L ASD (HHCC) toward H 2 O 2 and 1 O 2 was investigated in order to assess the propensity of the anti-sigma factor domain zinc nger site to be oxidized by these two oxidants in comparison with other zinc ngers. The reaction of Zn$L ASD (HHCC) (20 mM) with H 2 O 2 (1 mM) in phosphate buffer (10 mM, pH 7.0) was monitored by CD (Fig. S3C of ESI †). This reaction is slow and aer 15 h, the CD spectrum resembles that of zinc-free L ASD (HHCC), indicating that the peptide unfolds upon reaction with H 2 O 2 . The product of the reaction was identied by ESI/MS as a disulde (loss of two mass units). A similar CD spectrum was obtained by reacting Zn$L ASD (HHCC) with 2.5 eq. HOCl, a more efficient oxidant for zinc-bound thiolates known to form disuldes. 34 The kinetics of the reaction of Zn$L ASD (HHCC) with H 2 O 2 at 298 K was determined using previously described procedures, 19 monitoring either the loss of the LMCT absorption in the UV or zinc release by using 4-(2-pyridylazo)resorcinol (PAR), which forms the Zn(PAR) 2 complex with intense absorption in the visible when Zn 2+ is released from the peptide upon oxidation. The PAR assay is not recommended to follow the oxidation of Zn(Cys) 3 In previous studies, 21, 22 we have shown that the reaction of Zn(Cys) 4 KAKAQKLKAKAA-NH 2 (F4). Digestion of both HPLC fractions gave unaltered N-terminal fragments F1 and F2, meaning that neither His2 nor Tyr11 are photooxidized. However, different patterns were observed for the two cysteine-containing fragments F3 and F4 (Table S1 of ESI †). For both HPLC fractions, no mass peak corresponding to the possible F3-F4 disulde was detected. For the fraction eluting at 20.3 min, fragment F3 is unaltered but fragment F4 was detected in three distinct chemical forms: unaltered and with increase of 32 and 48 mass units. The product with a 32 mass unit increase was ascribed to the oxidation of Cys34 into a sulnate by comparison to previous studies. 21, 22 This was conrmed by the loss of 66 mass units corresponding to H 2 SO 2 upon MS/MS fragmentation. The formation of a sulnate upon photooxidation of metal-bound thiolate has already been reported in many instances for Pt, [35] [36] [37] Ni, 38 Pd, 38 Co 39-41 and Cd 42 complexes thereby supporting the formation of a sulnate for Zn-bond cysteines in Zn$L ASD (HHCC) but the product with a 48-mass unit increase is more intriguing. As F4 does not contain any amino acid prone to oxygen incorporation upon photooxidation other than Cys34 (i.e. His, Tyr, Trp or Met), this product could only be ascribed to the formation of a sulfonate on Cys34. This hypothesis is supported by the formation of glutathione sulfonate in the case of photooxidation of glutathione. 43 Nevertheless, the mechanism of the formation of this product, especially the breaking of the O-O bond in the putative RS(O)(O)-OO À intermediate remains unclear. Altogether, the fraction eluting at 20.3 min contains the unoxidized peptide L ASD (HHCC) as expected but also L ASD (-HHCC SO 2 ) and L ASD (HHCC SO 3 ) oxidation products in which Cys34 was photooxidized into a sulnate and a sulfonate, respectively (Fig. 5A ). For the fraction eluting at 18.1 min, only a 32-mass unit increase was detected for F3, revealing photooxidation of Cys31 into a sulnate (conrmed by loss of 66 mass units upon MS/MS fragmentation). Photooxidation of Cys31 rather than Tyr20 or His27 in F3 was supported by unaltered F1 fragment, which contains also histidine and tyrosine, and was further demonstrated by the loss of 66 Da corresponding to H 2 SO 2 upon MS-MS fragmentation. F4 appears within three different forms: unaltered and with +32 and +48 mass units. This indicates the presence of Cys34 in reduced, sulnate and sulfonate forms in the fraction eluting at 18.1 min. Therefore, this fraction contains three peptides: the primary oxidation product L ASD (HHC (Fig. 5B) . Noteworthy, mass analysis always revealed the presence of overoxidation products, even at short irradiation times, indicating that the rate of formation of overoxidation products is at least comparable to the rate of formation of primary oxidation products L ASD (HHCC ) 21 following a procedure described previously. 21, 22 The method consists in comparing the consumption of the zinc nger peptide and the reference compound by HPLC (ESI). In such a competitive photooxidation experiment, the ratio of the rate constants k r1 and k r2 of two compounds C 1 and C 2 is given by eqn (1) where [C i ] 0 and [C i ] f are the concentrations of compound C i before and aer photooxidation, respectively.
44,45
Since we were not able to separate unreacted L ASD (HHCC) and L ASD (HHCC SO 2 ) by HPLC and as overoxidation are rapidly formed, this method underestimates the consumption of L ASD (HHCC) and yields a sizeable underestimation of k r . Nevertheless, a lower limit of 3.9 Â 10 6 M À1 s À1 for k r (Zn$L ASD (HHCC)) was calculated from the competition experiments. Finally, CD was used to assess the consequences of 1 O 2 oxidation of Zn$L ASD (HHCC) on the peptide fold. As shown in Fig. 5C , photooxidation causes dramatic loss of helical structure, attesting of peptide unfolding.
Discussion
Design and characterization of the anti-sigma factor domain zinc nger model
For several years, we have been developing peptidic zinc nger models of small size in order to study the reactivity of zinc nger sites toward reactive oxygen species such as H 2 O 2 , [18] [19] [20] sequences. This affords models that reproduce almost perfectly the fold of native zinc nger domains around the Zn 2+ ion with a minimal set of amino acids. The small size of these models allowed us to characterize oxidation products and to provide reliable kinetic data to describe the reactivity of zinc ngers. The CPLT design is well suited to zinc nger sites harbouring a CXXC motif in a b-hairpin loop. However, the elaboration of a CPLT model was not possible for the anti-sigma factor domain due to its 3-helix core that supports the four Zn
2+
-binding amino acids. Therefore, we decided to keep this core but to reduce the size of the anti-sigma factor domain sequence as much as possible without altering its fold around Zn
. Re-engineering of the amino acid sequence allowed us to get a soluble 46-amino acid protein that folds upon Zn 2+ binding and adopts the same conformation as that found in the sigma factor/anti-sigma factor complex. The design strategy used to elaborate this model revealed some important features: (i) it is necessary to avoid clustering of negatively or positively charged amino acids on the surface to provide sufficient solubility to the model, (ii) once the Zn 2+ ion coordinated to the H-X 3 -C-X 2 -C motif, the constitution of a hydrophobic core within the heart of the 3-helix structure is most probably the driving force for the protein to get the proper folding; and (iii) the N-terminal histidine is absolutely required for conformational stability, providing at least 4 kcal mol 22 Unfortunately, all photooxidation products could not be separated by HPLC precluding precise determination of the chemical reaction rate constant k r . 21, 22 This was not the case in previous studies. Indeed, the size of the Zn$L ASD (HHCC) model is large compared to our other previously described models (46 versus ca. 25 amino acids), rendering HPLC separation less sensitive to changes occurring at a single amino acid position. Hence, the size of the model clearly matters for optimal separation and the smaller the model, the more detailed the molecular information. Nevertheless, a lower limit of 3.9 Â 10 6 M À1 s À1 could be determined for k r . The observation of at least two overoxidation productseven at short irradiation time -in the peak eluting at 20.3 min (Fig. 5A) 
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Based on our NMR structure of Zn$L ASD (HHCC) and the pdb le 1MEY 47 for Zn$CP-1(CCHH), we found that the former has higher sulfur solvent accessible surface area (8.8Å 2 vs. 4.1Å
2 ) and less NH/S hydrogen bonds (1 vs. 3). Therefore, these two factors support the greater reactivity of the anti-sigma factor domain zinc nger model compared to the classical bba model.
Biological relevance
Zinc binding to ChrR and formation of the Zn(Cys) 2 (His) 2 zinc nger site of ChrR is needed to ensure its proper folding and sequestering of s E . 8 Plus, it was demonstrated that the antisigma factor domain of ChrR is sufficient to sequester s E . 
Conclusions
In this article, we have described the elaboration of a model for the Zn(Cys) 2 (His) 2 zinc nger site of the anti-sigma factor domain of ChrR, a protein involved in transcriptional response to 1 O 2 in several bacteria. This site has a special topology among zinc ngers and its role in 
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